Search research articles
Contact Us
Filters
Showing results (381-390 of 398) with videos related to
Page
of 40
Sort By:
American Journal of Hematology
|
June 21, 2021
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry
Juan-Carlos Hernández-Boluda, Arturo Pereira, Nicolaus Kröger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2024
Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies
Esteban Arrieta-Bolaños, Edouard F Bonneville, Pietro Crivello, et al.
Haematologica
|
June 30, 2022
Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modeling
Sarah Lawless, Simona Iacobelli, Nina Simone Knelange, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 23, 2021
IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study
Sarah Lawless, Giulia Sbianchi, Curly Morris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 7, 2016
Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research
Victoria T Potter, Simona Iacobelli, Anja van Biezen, et al.
Blood
|
May 21, 2011
Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party
Thomas Daikeler, Myriam Labopin, Massimo Di Gioia, et al.
Implementation Science Communications
|
April 10, 2021
Mixed-methods economic evaluation of the implementation of tobacco treatment programs in National Cancer Institute-designated cancer centers
Ramzi G Salloum, Heather D'Angelo, Ryan P Theis, et al.
Biotechnology and Bioengineering
|
July 30, 2020
Toward in silico CMC: An industrial collaborative approach to model-based process development
David Roush, Dilip Asthagiri, Deenesh K Babi, et al.
British Journal of Haematology
|
April 5, 2024
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT
Francesco Onida, Luuk Gras, Junran Ge, et al.
Nature Communications
|
May 27, 2015
Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma
Bhairavi Swaminathan, Guðmar Thorleifsson, Magnus Jöud, et al.
Page
of 40
Search research articles
Search
Showing results (381-390 of 398) with videos related to
Sort By:
Page
of 40
American Journal of Hematology
|
June 21, 2021
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry
Juan-Carlos Hernández-Boluda, Arturo Pereira, Nicolaus Kröger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2024
Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies
Esteban Arrieta-Bolaños, Edouard F Bonneville, Pietro Crivello, et al.
Haematologica
|
June 30, 2022
Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modeling
Sarah Lawless, Simona Iacobelli, Nina Simone Knelange, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 23, 2021
IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study
Sarah Lawless, Giulia Sbianchi, Curly Morris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 7, 2016
Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research
Victoria T Potter, Simona Iacobelli, Anja van Biezen, et al.
Blood
|
May 21, 2011
Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party
Thomas Daikeler, Myriam Labopin, Massimo Di Gioia, et al.
Implementation Science Communications
|
April 10, 2021
Mixed-methods economic evaluation of the implementation of tobacco treatment programs in National Cancer Institute-designated cancer centers
Ramzi G Salloum, Heather D'Angelo, Ryan P Theis, et al.
Biotechnology and Bioengineering
|
July 30, 2020
Toward in silico CMC: An industrial collaborative approach to model-based process development
David Roush, Dilip Asthagiri, Deenesh K Babi, et al.
British Journal of Haematology
|
April 5, 2024
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT
Francesco Onida, Luuk Gras, Junran Ge, et al.
Nature Communications
|
May 27, 2015
Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma
Bhairavi Swaminathan, Guðmar Thorleifsson, Magnus Jöud, et al.
Page
of 40